Search Results - Jack Bleesing

Refine Results
  1. 1
    Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency

    Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency by Rebecca Marsh, Jack Bleesing, Alexandra H. Filipovich

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH

    Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH by Tamar Rubin, Kejian Zhang, Carrie Gifford, Adam Lane, Sharon Choo, Jack Bleesing, Rebecca Marsh

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked Lymphoproliferative Disease Type 1

    Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked Lymphoproliferative Diseas... by Rebecca Marsh, Jack Bleesing, Shanmuganathan Chandrakasan, Michael B. Jordan, Stella M. Davies, Alexandra H. Filipovich

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases

    Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases by Hilary Haines, Jack Bleesing, Stella M. Davies, Lindsey Hornung, Michael B. Jordan, Rebecca Marsh, Alexandra H. Filipovich

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis

    Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis by Sabine Mellor-Heineke, Joyce Villanueva, Michael B. Jordan, Rebecca Marsh, Kejian Zhang, Jack Bleesing, Alexandra H. Filipovich, Kimberly Risma

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease

    XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease by Rebecca Marsh, Lisa Madden, Brenda J. Kitchen, Rajen Mody, Brad McClimon, Michael B. Jordan, Jack Bleesing, Kejian Zhang, Alexandra H. Filipovich

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

    Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome by Jack Bleesing, Margaret R. Brown, Stephen E. Straus, Janet K. Dale, Richard M. Siegel, Michele M. Johnson, Michael J. Lenardo, Jennifer M. Puck, Thomas A. Fleisher

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

    Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial by Karen L. Bride, Tiffaney L. Vincent, Kim Smith‐Whitley, Michele P. Lambert, Jack Bleesing, Alix E. Seif, Catherine S. Manno, James T. Casper, Stephan A. Grupp, David T. Teachey

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy

    Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy by Nicholas J. Gloude, Christopher E. Dandoy, Stella M. Davies, Kasiani C. Myers, Michael B. Jordan, Rebecca Marsh, Ashish Kumar, Jack Bleesing, Ashley Teusink‐Cross, Sonata Jodele

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

    Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation by Rebecca Marsh, Gretchen Vaughn, Mi‐Ok Kim, Dandan Li, Sonata Jodele, Sarita Joshi, Parinda A. Mehta, Stella M. Davies, Michael B. Jordan, Jack Bleesing, Alexandra H. Filipovich

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

    Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop by João Bosco Oliveira, Jack Bleesing, Umberto Dianzani, Thomas A. Fleisher, Elaine S. Jaffe, Michael J. Lenardo, Frédéric Rieux‐Laucat, Richard M. Siegel, Helen C. Su, David T. Teachey, V. Koneti Rao

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT

    Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT by Benjamin L. Laskin, Jens Goebel, Stella M. Davies, Jane Khoury, Jack Bleesing, Parinda A. Mehta, A.H. Filipovich, Zachary Paff, Julia Lawrence, Hong-Jing Yin, Susan L. Pinkard, Sonata Jodele

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency

    A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency by Rebecca Marsh, Joyce Villanueva, Kejian Zhang, Andrew L. Snow, Helen C. Su, Lisa Madden, Rajen Mody, Brenda J. Kitchen, Dan Marmer, Michael B. Jordan, Kimberly Risma, Alexandra H. Filipovich, Jack Bleesing

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Functional reprogramming of regulatory T cells in the absence of Foxp3

    Functional reprogramming of regulatory T cells in the absence of Foxp3 by Louis‐Marie Charbonnier, Ye Cui, Emmanuel Stephen‐Victor, Hani Harb, David López, Jack Bleesing, M. Garcia-Lloret, Karin Chen, Ahmet Özen, Peter Carmeliet, Ming O. Li, Matteo Pellegrini, Talal A. Chatila

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

    Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome by David T. Teachey, Robert Greiner, Alix E. Seif, Edward F. Attiyeh, Jack Bleesing, John Choi, Catherine S. Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen, Kathleen E. Sullivan, Hongming Zhuang, Daniel S. Wechsler, Stephan A. Grupp

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

    Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults by Sonata Jodele, Stella M. Davies, Adam Lane, Jane Khoury, Christopher E. Dandoy, Jens Goebel, Kasiani C. Myers, Michael Grimley, Jack Bleesing, Javier El‐Bietar, Gregory Wallace, Ranjit S. Chima, Zachary Paff, Benjamin L. Laskin

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome

    Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome by Andrew Lindsley, Howard M. Saal, Thomas Andrew Burrow, Robert J. Hopkin, Oleg A. Shchelochkov, Pooja Khandelwal, Changchun Xie, Jack Bleesing, Lisa Filipovich, Kimberly Risma, Amal Assa’ad, Phillip A. Roehrs, Jonathan A. Bernstein

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

    Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab by Rebecca Marsh, Carl E. Allen, Kenneth L. McClain, Joanna Weinstein, Julie Kanter, Jodi Skiles, Nadine D. Lee, Shakila P. Khan, Julia Lawrence, Jun Qin Mo, Jack Bleesing, Alexandra H. Filipovich, Michael B. Jordan

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency

    Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency by Andrew L. Snow, Rebecca Marsh, Scott M. Krummey, Philip Roehrs, Lisa R. Young, Kejian Zhang, Jack van Hoff, Deepali Dhar, Kim E. Nichols, Alexandra H. Filipovich, Helen C. Su, Jack Bleesing, Michael J. Lenardo

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

    An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphoh... by Rebecca Marsh, Mi‐Ok Kim, Chunyan Liu, Denise Bellman, Laura K. Hart, Michael Grimley, Ashish Kumar, Sonata Jodele, Kasiani C. Myers, Sharat Chandra, Tom Leemhuis, Parinda A. Mehta, Jack Bleesing, Stella M. Davies, Michael B. Jordan, Alexandra H. Filipovich

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: